Long-term Survival Outcomes With Intravesical Nanoparticle Albumin-bound Paclitaxel for Recurrent Non–muscle-invasive Bladder Cancer After Previous Bacillus Calmette-Guérin Therapy-Reference-Cited by-同舟云学术

Long-term Survival Outcomes With Intravesical Nanoparticle Albumin-bound Paclitaxel for Recurrent Non–muscle-invasive Bladder Cancer After Previous Bacillus Calmette-Guérin Therapy

Published:2017-05 Issue: Volume:103 Page:149-153
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Robins Dennis J.,Sui Wilson,Matulay Justin T.,Ghandour Rashed,Anderson Christopher B.,DeCastro G. Joel,McKiernan James M.

Publisher

Elsevier BV

Subject

Urology

Reference29 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. Epidemiology and risk factors of urothelial bladder cancer;Burger;Eur Urol,2013

3. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline;Chang;J Urol,2016

4. Bacillus Calmette-Guerin therapy for superficial bladder cancer: a 10-year followup;Herr;J Urol,1992

5. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study;Lamm;J Urol,2000

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Strategies for BCG Unresponsive Non-muscle Invasive Bladder Cancer;annals of urologic oncology;2024-08-29

2. Experimental and New Approaches for Bladder Preservation in Intermediate and High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC);Research and Reports in Urology;2024-04

3. CTEN-induced TGF-β1 expression facilitates EMT and enhances paclitaxel resistance in bladder cancer cells;American Journal of Translational Research;2024

4. A systematic review of nanocarriers for treatment of urologic cancers;Urologic Oncology: Seminars and Original Investigations;2023-12

5. Optimal Management of Bacillus Calmette-Guérin–Refractory Non–Muscle-Invasive Bladder Cancer in 2023;Journal of Urologic Oncology;2023-11-30